HLA-DR antigen expression in intestinal-type and diffuse-type gastric carcinoma

Area of Science:

• Immunogenetics
• Oncology
• Pathology

Background:

• Gastric carcinoma is classified into intestinal and diffuse types based on histology.
• Human Leukocyte Antigen (HLA) molecules play crucial roles in immune responses.
• HLA-DR, a Class II HLA antigen, is involved in antigen presentation.

Purpose of the Study:

• To investigate the expression patterns of HLA-DR antigen in different subtypes of gastric carcinoma.
• To determine if HLA-DR expression can differentiate between intestinal and diffuse-type gastric carcinoma.

Main Methods:

• Analysis of HLA-DR antigen expression in 41 gastric carcinoma cases (23 intestinal-type, 18 diffuse-type).
• Utilized a monoclonal antibody reactive to HLA-DR in formalin-fixed, paraffin-embedded tissue sections.
• Employed a modified Lauren classification for tumor typing.

Main Results:

• HLA-DR antigen was expressed in 17 out of 23 intestinal-type gastric carcinomas.
• Only 2 out of 18 diffuse-type gastric carcinomas showed positive HLA-DR expression.
• Staining for HLA-DR was generally stronger and more widespread in intestinal-type compared to diffuse-type.

Conclusions:

• The differential expression and staining patterns of HLA-DR antigen suggest distinct biological behaviors.
• Findings support the classification of intestinal and diffuse types as separate subtypes of gastric carcinoma.
• HLA-DR expression may serve as a potential marker for distinguishing gastric carcinoma subtypes.